Trial · NCT01647828
Adverse events5,310
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 5,310
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Thrombocytopenia | Blood and lymphatic system disorders | P1B: OMP-59R5 2.5 mg/kg + Gem | 3 | 5 | |
| other | Thrombocytopenia | Blood and lymphatic system disorders | P1B: OMP-59R5 5 mg/kg + Gem | 2 | 4 | |
| other | Thrombocytopenia | Blood and lymphatic system disorders | P1B: OMP-59R5 5 mg/kg + Nab-P + Gem | 4 | 4 | |
| other | Thrombocytopenia | Blood and lymphatic system disorders | P1B: OMP-59R5 7.5 mg/kg + Nab-P + Gem | 5 | 6 | |
| other | Thrombocytopenia | Blood and lymphatic system disorders | P1B: OMP-59R5 10 mg/kg + Nab-P + Gem | 5 | 6 | |
| other | Thrombocytopenia | Blood and lymphatic system disorders | P1B: OMP-59R5 12.5 mg/kg + Nab-P + Gem | 2 | 3 | |
| other | Thrombocytopenia | Blood and lymphatic system disorders | P1B: OMP-59R5 15 mg/kg + Nab-P + Gem | 7 | 12 | |
| other | Thrombocytopenia | Blood and lymphatic system disorders | P2: Placebo + Nab-P + Gem | 38 | 85 | |
| other | Thrombocytopenia | Blood and lymphatic system disorders | P2: OMP-59R5 15 mg/kg + Nab-P + Gem | 62 | 87 | |
| other | Anemia | Blood and lymphatic system disorders | P1B: OMP-59R5 2.5 mg/kg + Gem | 4 | 5 | |
| other | Anemia | Blood and lymphatic system disorders | P1B: OMP-59R5 5 mg/kg + Gem | 2 | 4 | |
| other | Anemia | Blood and lymphatic system disorders | P1B: OMP-59R5 5 mg/kg + Nab-P + Gem | 2 | 4 | |
| other | Anemia | Blood and lymphatic system disorders | P1B: OMP-59R5 7.5 mg/kg + Nab-P + Gem | 3 | 6 | |
| other | Anemia | Blood and lymphatic system disorders | P1B: OMP-59R5 10 mg/kg + Nab-P + Gem | 5 | 6 | |
| other | Anemia | Blood and lymphatic system disorders | P1B: OMP-59R5 12.5 mg/kg + Nab-P + Gem | 2 | 3 | |
| other | Anemia | Blood and lymphatic system disorders | P1B: OMP-59R5 15 mg/kg + Nab-P + Gem | 9 | 12 | |
| other | Anemia | Blood and lymphatic system disorders | P2: Placebo + Nab-P + Gem | 46 | 85 | |
| other | Anemia | Blood and lymphatic system disorders | P2: OMP-59R5 15 mg/kg + Nab-P + Gem | 50 | 87 | |
| other | Neutropenia | Blood and lymphatic system disorders | P1B: OMP-59R5 2.5 mg/kg + Gem | 2 | 5 | |
| other | Neutropenia | Blood and lymphatic system disorders | P1B: OMP-59R5 5 mg/kg + Gem | 0 | 4 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT01647828/events